Business
Australian shares lose momentum, after Wall Street jumps on coronavirus vaccine developments – ABC News
Australian shares slip, despite Wall Street rising sharply on the back of COVID-19 vaccine developments and several multi-billion-dollar deals, while Qantas considers moving its Sydney headquarters to cut costs.
Australian shares have been flat for most of the day, even after Wall Street jumpedon the back of COVID-19 vaccine developments and several multi-billion-dollar deals.
Key points:
- The S&P 500 has surged 54pc since late March
- The ASX 200 has jumped 34pc in the past six months
- Central banks in the US, UK and Japan will decide on interest rates this week
By 2:15pm AEST, the benchmark ASX 200 index had slipped (-0.2pc) to 5,980 points.
Resource stocks were a…
-
Noosa News24 hours agoWilliam Robinson dies aged 89
-
General23 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
General23 hours agoMatt Wright wanted to hinder investigations into chopper crash ‘at almost any cost’, jury hears
-
Business10 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened